OGDEN, Utah--(BUSINESS WIRE)--Setpoint Systems (http://www.setpointusa.com), a leader in design and manufacture of custom lean automation solutions and manufacturing ...

SetPoint System® is first-of-its-kind neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis VALENCIA, Calif., November 24, 2025--(BUSINESS WIRE) ...

Treatment follows recent Food and Drug Administration approval of the SetPoint System for treatment of RA, a bioelectronic medicine breakthrough Northwell is first to implant patient with FDA-approved ...

The U.S. Food and Drug Administration has approved the SetPoint System, a neuroimmune modulation device for the treatment of adults living with moderate-to-severe rheumatoid arthritis (RA). The ...

Four presentations highlight 12-month clinical outcomes, as well as MRI-assessed joint protection and patient perspectives supporting the SetPoint System as first-of-its-kind treatment for rheumatoid ...

SetPoint Medical has submitted a premarket approval (PMA) application to the US Food and Drug Administration (FDA) for a neuroimmune modulation device aimed at treating rheumatoid arthritis (RA) ...

Credit: SetPoint Medical. The SetPoint System is a rechargeable neurostimulation device that is implanted on the vagus nerve. Treatment with the SetPoint System, a neuroimmune modulation device, was ...

SALT LAKE CITY--(BUSINESS WIRE)--D.A. Davidson & Co. announced today that it served as exclusive financial advisor to both Setpoint Systems, a leading provider of automation solutions, and Setpoint, ...

NEW HYDE PARK, N.Y. & VALENCIA, Calif.--(BUSINESS WIRE)--Northwell Health and SetPoint Medical today announced that Northwell is the first health system to provide the recent U.S. Food and Drug ...